Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

BioSyent to Present at Upcoming Investor Conference


TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company") (TSX Venture: RX) is pleased to announce that it will be presenting at the Midwest IDEAS Investor Conference at The Gwen in Chicago, Illinois. Mr.  René  Goehrum, BioSyent's President  and  CEO, will present  to  investors  an overview  of  BioSyent's business and  corporate  activities on Wednesday, August 29th at 9:20 a.m. ET. Mr. Goehrum will also be available for one-on-one meetings during the day on August 29th.  Interested investors can request meetings with Mr. Goehrum through the online conference platform: https://www.meetmax.com/sched/event_48313/entity_login.html?attendee_role_id=COMPANY. 

  
About BioSyent Inc.

Listed on the TSX Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients.  BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, hospital and international business units.  

As of the date of this press release, the Company has 14,519,603 common shares issued and outstanding.

For a direct market quote for the TSX Venture Exchange and other Company financial information, please visit www.tmxmoney.com.

For further information please contact:

Mr. René C. Goehrum
President and CEO
BioSyent Inc.
Tel: (905) 206-0013
E-Mail: [email protected]
Web: www.biosyent.com


These press releases may also interest you

at 17:01
Moonstone Nutrition Launches New Investment Opportunity on StartEngine to Fuel Company Growth and Prevent Painful Kidney Stones
Moonstone Nutrition, a pioneering nutraceutical company dedicated to the prevention of kidney stones, is thrilled to announce the launch of its latest investment campaign on StartEngine, one of the leading equity crowdfunding platforms. This exciting...

at 17:00
Innovative Eyewear, Inc. Announces Closing of $1.025 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") , the developer and seller of smart eyewear, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the issuance...

at 16:52
C?tisCare Launches Fourth Annual Hyperbaric Awaretm National Campaign To Elevate Awareness Of Hyperbaric Oxygen Therapy
Since its inception in 2021, Hyperbaric Awareness USAtm, a CutisCare initiative, has designated May Hyperbaric Awareness Month and is proud to announce the launch of the fourth annual Hyperbaric Awaretm national campaign to elevate awareness of...

at 16:35
Outset Medical to Present at Upcoming Investor Conferences
Outset Medical, Inc. ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate at the BofA Securities Health Care...

at 16:35
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Bank of America...

at 16:30
Remote Pregnancy Care Innovator Nuvo Group Ltd. Becomes Public Company Through Completion of Business Combination with LAMF Global Ventures Corp.
Holdco Nuvo Group D.G Ltd ("Nuvo"), a pioneer in remote pregnancy monitoring, today announced completion of its business combination with LAMF Global Ventures Corp. I  (NASDAQ:...

More news about Health...


News published on and distributed by: